Paper8026323
A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development.
Barres BA and 2 others. Development, 1994. Cited by 520 papers, by iCite.
Cite this record
ConductScience Library. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Papers, record 8026323. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8026323
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glucocorticoids | Major topic |
| Oligodendroglia | Major topic |
| Stem Cells | Major topic |
| Thyroid Hormones | Major topic |
| Tretinoin | Major topic |
| Animals | |
| Cell Differentiation | |
| Cells, Cultured | |
| Dexamethasone | |
| Optic Nerve | |
| Rats | |
| Rats, Sprague-Dawley |
Source PubMed
Cited by226
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 520 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42475563 | Glucocorticoid receptors in oligodendrocyte precursor cells regulate hippocampal network plasticity and stress-induced behavior in mice. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42475563 | PubMed |
| 41934103 | RXR Gamma Enables Oligodendrocyte Differentiation by Suppressing Sonic Hedgehog Signaling. | Glia | 2026 | https://conductscience.org/library/papers/41934103 | PubMed |
| 41697574 | Reactive OPCs in CNS Injury: From Functional Diversity to Therapeutic Translation. | Neurosci Bull | 2026 | https://conductscience.org/library/papers/41697574 | PubMed |
| 41102017 | DIO3 coordinates photoreceptor development timing and fate stability in human retinal organoids. | Genes Dev | 2026 | https://conductscience.org/library/papers/41102017 | PubMed |
| 40517802 | Iron and selenium: At the crossroads of development and death in oligodendrocytes. | Arch Biochem Biophys | 2025 | https://conductscience.org/library/papers/40517802 | PubMed |
| 40514588 | Myelin-axon interface vulnerability in Alzheimer's disease revealed by subcellular proteomics and imaging of human and mouse brain. | Nat Neurosci | 2025 | https://conductscience.org/library/papers/40514588 | PubMed |
| 40341870 | Controlled Antenatal Thyroid Screening Study III: Effects of Gestational Thyroid Status on Brain Microstructure. | J Clin Endocrinol Metab | 2025 | https://conductscience.org/library/papers/40341870 | PubMed |
| 40275379 | A 3D human iPSC-derived multi-cell type neurosphere system to model cellular responses to chronic amyloidosis. | J Neuroinflammation | 2025 | https://conductscience.org/library/papers/40275379 | PubMed |
| 40065911 | Intrinsic retinoic acid synthesis is required for oligodendrocyte progenitor expansion during CNS remyelination. | Front Cell Neurosci | 2025 | https://conductscience.org/library/papers/40065911 | PubMed |
| 39872018 | Cryopreservation of primary neonatal rat oligodendrocytes and recapitulation of in vitro oligodendrocyte characteristics. | Front Cell Neurosci | 2024 | https://conductscience.org/library/papers/39872018 | PubMed |
| 39820244 | Incomplete remyelination via therapeutically enhanced oligodendrogenesis is sufficient to recover visual cortical function. | Nat Commun | 2025 | https://conductscience.org/library/papers/39820244 | PubMed |
| 39537633 | Pharmacogenomic screening identifies and repurposes leucovorin and dyclonine as pro-oligodendrogenic compounds in brain repair. | Nat Commun | 2024 | https://conductscience.org/library/papers/39537633 | PubMed |
| 39464332 | Overview of emerging therapies for demyelinating diseases. | World J Clin Cases | 2024 | https://conductscience.org/library/papers/39464332 | PubMed |
| 38701782 | Small-molecule-induced epigenetic rejuvenation promotes SREBP condensation and overcomes barriers to CNS myelin regeneration. | Cell | 2024 | https://conductscience.org/library/papers/38701782 | PubMed |
| 38655345 | A primary culture method for the easy, efficient, and effective acquisition of oligodendrocyte lineage cells from neonatal rodent brains. | Heliyon | 2024 | https://conductscience.org/library/papers/38655345 | PubMed |
| 38350432 | The Effects of Neuroactive Steroids on Myelin in Health and Disease. | Med Princ Pract | 2024 | https://conductscience.org/library/papers/38350432 | PubMed |
| 38030826 | Early, low-dose hydrocortisone and near-term brain connectivity in extremely preterm infants. | Pediatr Res | 2024 | https://conductscience.org/library/papers/38030826 | PubMed |
| 37925436 | Systemic and intrinsic functions of ATRX in glial cell fate and CNS myelination in male mice. | Nat Commun | 2023 | https://conductscience.org/library/papers/37925436 | PubMed |
| 37818718 | H3K27M mutant glioma: Disease definition and biological underpinnings. | Neuro Oncol | 2024 | https://conductscience.org/library/papers/37818718 | PubMed |
| 37765015 | Synthetic Thyroid Hormone Receptor-β Agonists Promote Oligodendrocyte Precursor Cell Differentiation in the Presence of Inflammatory Challenges. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37765015 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8026323
GET https://conductscience.org/api/papers/v1/8026323/cited_by?page=2